The impact of CpG island methylator phenotype and microsatellite instability on tumour budding in colorectal cancer

Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget

(2015)   Oncotarget

Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancers

(2011) Inti Zlobec et al.   HISTOPATHOLOGY

Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features

(2011) Inti Zlobec et al.   JOURNAL OF PATHOLOGY

Promoter Methylation of Specific Genes is Associated with the Phenotype and Progression of Colorectal Adenocarcinomas

(2010) Jin C. Kim et al.   ANNALS OF SURGICAL ONCOLOGY

The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status

(2010) A. M. Dahlin et al.   CLINICAL CANCER RESEARCH

Role of the Serrated Pathway in Colorectal Cancer Pathogenesis

(2010) Barbara Leggett et al.   GASTROENTEROLOGY

5-Fluorouracil Adjuvant Chemotherapy Does Not Increase Survival in Patients With CpG Island Methylator Phenotype Colorectal Cancer

(2010) Rodrigo Jover et al.   GASTROENTEROLOGY

Immune evasion of microsatellite unstable colorectal cancers

(2010) Matthias Kloor et al.   INTERNATIONAL JOURNAL OF CANCER

Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review

(2010) Katsuhiko Nosho et al.   JOURNAL OF PATHOLOGY

E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer

(2009) Otto Schmalhofer et al.   CANCER AND METASTASIS REVIEWS

Tumor Budding is a Strong and Reproducible Prognostic Marker in T3N0 Colorectal Cancer

(2008) Lai Mun Wang et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

MSI-H colorectal cancers preferentially retain and expand intraepithelial lymphocytes rather than peripherally derived CD8+ T cells

(2008) Kristi Baker et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Tumor Budding as an Index to Identify High-Risk Patients with Stage II Colon Cancer

(2008) Takatoshi Nakamura et al.   DISEASES OF THE COLON & RECTUM

Immune Response Against Frameshift-Induced Neopeptides in HNPCC Patients and Healthy HNPCC Mutation Carriers

(2008) Yvette Schwitalle et al.   GASTROENTEROLOGY

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

(2008) S. Ogino et al.   GUT

Molecular Classification and Correlates in Colorectal Cancer

(2007) Shuji Ogino et al.   JOURNAL OF MOLECULAR DIAGNOSTICS